- In May 2023, Enable Injections, Inc. entered into a partnership with Viridian Therapeutics, Inc., a biotech company based in the U.S., to expand their collaborative efforts in the field of drug delivery systems
- In January 2023, Tandem Diabetes Care, Inc. completed the acquisition of AMF Medical SA, the producer of the Sigi Patch Pump, enhancing its product portfolio for diabetes management solutions
- In June 2022, AbbVie received approval from the U.S. FDA for SKYRIZI, an interleukin-23 inhibitor, for the treatment of moderately to severely active Crohn’s disease. Administered through subcutaneous injection, it provides a self-administration option using the On-Body Injector
- In January 2022, Enable Injections secured USD 215 million in funding to further develop enFuse, a subcutaneous drug delivery system that includes a wearable delivery disc and a vessel transfer system, aimed at improving drug delivery efficiency
- In April 2020, Insulet Corporation, known for its Omnipod Insulin Management System, offered financial assistance to its U.S. customers affected by the pandemic, providing eligible individuals with up to a six-month supply of products free of charge to alleviate financial challenges
